Scarica l'app Stockscreener
0.4559
1.89%
-0.0088
Pre-mercato:
.45
-0.0059
-1.29%
Fractyl Health Inc Borsa (GUTS) Ultime notizie
Portfolio Shifts: Is Fractyl Health Inc undervalued by DCF analysis2026 Volatility Report & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Fractyl Health (GUTS) stock jumps 21% after hours: Here's what you should know - MSN
Fractyl Health, Inc. (GUTS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
If You Invested $1,000 in Fractyl Health (GUTS) - Stock Titan
Pharma News: Is Fractyl Health Inc benefiting from interest rate changes2026 Big Picture & Growth Oriented Trading Recommendations - baoquankhu1.vn
Fractyl Health (GUTS) Projected to Post Quarterly Earnings on Monday - MarketBeat
Fractyl Health Earnings Call: Revita Nears Key Pivotal Test - The Globe and Mail
Scalable Biotech Manufacturing Unlocks a $14B Market - Benzinga
HC Wainwright Forecasts Fractyl Health Q1 Earnings - marketbeat.com
Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), Merck & Company (MRK) and Abbott Laboratories (ABT) - The Globe and Mail
Fractyl Health, Inc. (NASDAQ:GUTS) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Market Recap: Is Fractyl Health Inc in a long term uptrend2026 Volume & Low Risk High Reward Ideas - baoquankhu1.vn
Short Interest in Fractyl Health, Inc. (NASDAQ:GUTS) Decreases By 55.7% - MarketBeat
Fractyl Health (NASDAQ:GUTS) Earns Buy Rating from Canaccord Genuity Group - MarketBeat
Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS) and Terns Pharmaceuticals (TERN) - The Globe and Mail
Fractyl Health FY2029 EPS Forecast Lifted by HC Wainwright - MarketBeat
Fractyl Health Faces Significant Compliance Risks Under Global Anti-Corruption and Sanctions Laws - TipRanks
BofA Securities Maintains Fractyl Health(GUTS.US) With Buy Rating - Moomoo
Fractyl Highlights Revita Progress and 2025 Financial Results - The Globe and Mail
Fractyl Health, Inc. Common Stock Q4 2025 Earnings Call Summary - Yahoo Finance
Fractyl Health (GUTS) Stock Jumps 21% After Hours: Here's What You Should Know - Benzinga
Fractyl Health Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Fractyl Health Inc (GUTS) Q4 2025 Earnings Call Highlights: Navigating Financial Challenges ... By GuruFocus - ca.investing.com
Fractyl Health outlines 2026 De Novo submission plans with pivotal Revita data expected in early Q4 - MSN
Disease-Modifying Therapies for Obesity and Type 2 Diabetes: Revita and Rejuva Pipeline Overview - Minichart
Fractyl Health Inc’s 2025 Q4 Call: CPT Code Timing, Regulatory Readiness, and Ablation Targets Don’t Align - Bitget
GUTS: Pivotal study enrollment complete; Revita advances toward key 2026 data and de novo submission - TradingView
Fractyl Health Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: Fractyl Health Q4 2025 sees cost cut, stock dips - Investing.com
Fractyl Health (NASDAQ:GUTS) Posts Narrower-Than-Expected Loss Ahead of Pivotal Trial Readout - ChartMill
FRACTYL HEALTH ($GUTS) Releases Q4 2025 Earnings - Quiver Quantitative
Fractyl Health (NASDAQ:GUTS) Releases Earnings Results, Misses Expectations By $0.13 EPS - MarketBeat
Fractyl Health Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates - The Manila Times
Fractyl Health 2025 10-K: $0M Revenue, Net Loss $140.954M - TradingView
Fractyl Health (NASDAQ: GUTS) outlines Revita device and Rejuva gene therapy plans - Stock Titan
Fractyl Health, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Fractyl Health (Nasdaq: GUTS) widens 2025 loss but advances pivotal Revita - Stock Titan
Fractyl Health, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Fractyl Health, Inc. (GUTS) loses 77.6% in 4 weeks, here's why a trend reversal may be around the corner - MSN
Fractyl Health (NASDAQ:GUTS) - intelligentinvestor.com.au
H.C. Wainwright Maintains a Buy Rating on Fractyl Health, Inc. (GUTS) with an $8 Price Target - Insider Monkey
Fractyl Health, Inc. (GUTS) moves to buy: Rationale behind the upgrade - MSN
Fractyl Health Receives Nasdaq Minimum Bid Price Notice - The Globe and Mail
Fractyl Health (Nasdaq: GUTS) faces Nasdaq minimum bid-price warning - Stock Titan
Fractyl Health to report fourth quarter and full year 2025 financial results and provide business updates on March 24, 2026 - MarketScreener
Fractyl Health To Report Fourth Quarter And Full Year 2025 Financial Results And Provide Business Updates On March 24, 2026 - TradingView
Fractyl Health to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Updates on March 24, 2026 - The Manila Times
Fractyl Health to Report Fourth Quarter and Full Year 2025 - GlobeNewswire
Investment Report: What is the dividend yield of Fractyl Health Inc2026 Valuation Update & Growth Oriented Trade Recommendations - baoquankhu1.vn
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):